Listing 1 - 10 of 95 | << page >> |
Sort by
|
Choose an application
Nederland liep voorop in vrijheid en tolerantie, vooral qua drugsbeleid. Het leidde tot een uitbundige cultuur, beschermd door de GGD en de politie. In deze context groeide een industrie die uitblinkt in variatie, organisatie en ontwrichting van de gewone samenleving. Deze ondermijnende criminaliteit staat in het brandpunt van de belangstelling. De huidige overheidsorganisatie lijkt slecht toegerust voor een effectieve aanpak ervan. Ruim vijf jaar geleden werd een Taskforce ingesteld om de problemen in Brabant en Zeeland te lijf te gaan. De auteurs analyseren de maatschappelijke context van de problemen en berichten over de onorthodoxe wijze waarop deze in het zuiden van het land zijn aangepakt. Ondermijning verwijst naar de illegale warboel die groeit in een complexe omgeving. Maar er ontstond een interessante tegenstrategie.
strafrecht --- drugbeleid --- criminaliteit --- Netherlands
Choose an application
Human medicine --- drugbeleid --- drugpreventie
Choose an application
The first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance. Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience. Pharmacovigilance in psychiatry provides a thorough introduction to this field but goes on to explore advanced themes such as methodologies and resources used for pharmacovigilance in psychiatry, challenges as well as most recent developments to this field, making it suitable for under-graduates, graduate and post-doctoral students and persons working pharmacovigilance who seek to broaden their knowledge on this subject.
Pharmacology. Therapy --- farmacologie --- psychofarmaca --- drugbeleid
Choose an application
This book is a comprehensive resource on psychotropic medications, detailing the latest methods for defining their characteristics, their use in different patient populations, and drug-drug interactions; an important collection of information forclinicians, students, researchers, and members of the pharmaceutical industry alike. The first section provides the foundational principles of these drugs. Mathematical modeling of parameters that affect their entryto,and exit from, the central nervous system (CNS) compartment are presented on an individual basis and then applied to target populations with specific disease states. Methods and characteristics that inform the transfer of these drugs from the laboratory bench to use in patient care are discussed, including imaging techniques, genetics and physiological barriers, such as the blood-brain barrier. The second section describes the characteristics of specific agents,nominally arranged intodifferent therapeutic categories and with reference crossover use in different disease states. The pharmacologic characteristics of different drug formulations are explored in the context of their ability to improve patient adherence. The third section focuses on drug-drug interactions.Psychotropic medications from different categories are frequently prescribed together,or alongside medications used to treat comorbid conditions, and the information provided is directly relevant to the clinic, as a result. The clinical application of pharmacokinetics and pharmacodynamics of CNS agents has made significant progress over the past 50 years and new information is reported by numerous publications in psychiatry, neurology, and pharmacology.Our understanding of the interrelationship between these medications, receptors, drug transporters, as well as techniques for measurement and monitoring their interactions,isfrequently updated. However, with information presented on a host of different platforms, and in different formats, obtaining the full picture can be difficult. This title aims to collate this information into a single source that can be easily interpreted and applied towards patient care by the clinical practitioner, and act as a reference for all others who have an interest in psychopharmacological agents.
Pharmacology. Therapy --- farmacologie --- psychofarmaca --- drugbeleid
Choose an application
Toxicology --- Pharmacology. Therapy --- farmacologie --- multimedia --- toxicologie --- drugbeleid
Choose an application
Pharmacology. Therapy --- Oncology. Neoplasms --- farmacologie --- oncologie --- drugbeleid
Choose an application
strafrecht --- drugbeleid --- criminaliteit --- Netherlands --- criminaliteit. --- drugs.
Choose an application
Pharmacology. Therapy --- Neuropathology --- neurologie --- farmacologie --- drugbeleid
Choose an application
Ethics and addiction --- Social policy --- drughulpverlening --- drugbeleid
Choose an application
This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development. The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.
Toxicology --- Pharmacology. Therapy --- farmacologie --- multimedia --- toxicologie --- drugbeleid
Listing 1 - 10 of 95 | << page >> |
Sort by
|